Abstract: We evaluated the inhibitory effect of 12 Chinese teas on leukocyte-type
12-lipoxygenase (LOX) activity. Tea catechins such as epigallocatechin gallate have been
known to exhibit leukocyte-type 12-LOX inhibition. Qing Shan Lu Shui, which contains
lower catechin levels than the other tested teas, suppressed leukocyte-type 12-LOX
activity. To characterize the bioactive components of Qing Shan Lu Shui, leukocyte-type
12-LOX inhibitory activity–guided fractionation of the aqueous ethanol extract of the tea
was performed, resulting in the isolation of two new monoterpene glycosides: liguroside A
(1) and B (2). The structures of compounds 1 and 2 were characterized as (2E,5E)-7-
hydroperoxy-3,7-dimethyl-2,5-octadienyl-O-(α-L-rhamnopyranosyl)-(1″→3′)-(4′″-O-transp-coumaroyl)-β-D-glucopyranoside and (2E,5E)-7-hydroperoxy-3,7-dimethyl-2,5-octa-dienylO-(α-L-rhamnopyranosyl)-(1″→3′)-(4′″-O-cis-p-coumaroyl)-β-D-glucopyranoside, respectively,
Comments